Logo image
(Acetato-κO)(acetato-κ2O,O′)[2-(3, 5-dimethyl-1H-pyrazol-1-yl-κN2)quinoline-κN]zinc(II)
Journal article   Open access   Peer reviewed

(Acetato-κO)(acetato-κ2O,O′)[2-(3, 5-dimethyl-1H-pyrazol-1-yl-κN2)quinoline-κN]zinc(II)

M H B Najib, A L Tan, David James Young, S W Ng and E R T Tiekink
Acta Crystallographica Section E: Structure Reports Online, Vol.68(Part 7), pp.m897-m898
2012
pdf
PDF - Published Version (Open Access)615.23 kBDownloadView
Published VersionPDF - Published Version (Open Access)CCBY_V2.0 Open Access
url
https://doi.org/10.1107/S1600536812025664View
Published Version

Abstract

The ZnII atom in the title compound, [Zn(C2H 3O2)2(C14H13N 3)], is coordinated by an N2O3 donor set defined by the quinolinyl- and pyrazolyl-N atoms of the chelating heterocyclic ligand, and three carboxylate-O atoms derived from the monodentate and bidentate carboxylate ligands. Distortions from the ideal square-pyramidal coordination geometry relate to the restricted bite angle of the chelating ligands, i.e. O - Zn - O = 59.65 (5) and N - Zn - N = 76.50 (6)°, and the close approach of the non-coordinating carbonyl atom [Zn⋯O = 2.858 (2) Ã…]. In the crystal, molecules are consolidated into a three-dimensional architecture by C - H⋯O interactions © 2012 International Union of Crystallography.

Details

Metrics

114 File views/ downloads
422 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Crystallography

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image